NEW YORK – Single-cell library prep firm 1CellBio has launched an early-access program in a bid to develop applications based on new targeted cell selection and sequencing capabilities that could expand sales of its droplet-based platform.
NEW YORK – Single-cell library prep firm 1CellBio has launched an early-access program in a bid to develop applications based on new targeted cell selection and sequencing capabilities that could expand sales of its droplet-based platform.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.